Sinnreich Matthew Phillip 4/A
4/A · Organicell Regenerative Medicine, Inc. · Filed Nov 3, 2022
Insider Transaction Report
Form 4/AAmended
Sinnreich Matthew Phillip
DirectorPresident and Acting CEO
Transactions
- Other
Common Stock, $0.001 par value
2022-10-31−6,976,000→ 0 total(indirect: See Footnote)
Footnotes (1)
- [F1]On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares.